Skip to main content
Important update on COVID-19

Important updates on COVID-19

ANSTO is committed to the health and wellbeing of its people, partners, customers, and communities. In response to the COVID-19, we have made some changes to our operations.

From 25 May we will begin Phase 1 of a transition to more campus-based work. However, those staff who can work from home will continue to do so.

View ANSTO's COVIDSafe Plan NSW 

View ANSTO's COVIDSafe Plan Victoria

ANSTO’s operations are unique within Australia in that we are home to Australia’s most significant landmark and national infrastructure for research. Because the reactor provides critical nuclear medicine, we have maintained its operations during the COVID crisis. More broadly, our work improves human health, saves lives, builds our industries and protects the environment. 

Apart from essential operations in the nuclear precinct, ANSTO staff across all three of our campuses continue to work remotely. These adjustments support the Australian Government’s measures to slow and help suppress the spread of the virus within the community and also protect ANSTO’s critical role in providing nuclear medicines for Australians. 

We have made modifications that impact the scientific user community and public engagement activities as outlined below.

COVID-19 Updates

User services for research and industry

user services covid19

Please refer to the user access page below for COVID-19 updates and accessing ANSTO's Research facilities.

Visit User Access

Public tours and School group tours

OPAL tours and events covid19 update

All public tours and school group tours are now on hold until further notice. Schools and visitors who have booked a tour are being contacted by the ANSTO Discovery Centre. Please contact the education team should you have any questions.

nandin Innovation Centre will continue to operate as usual for our members.

Products and services

Covid19 products and services v2


Many of our operational and technical staff have returned to work on site, while our professional staff continue to work from home when possible. All client meetings will continue to be conducted via video conferencing. 

We'll continue to provide regular updates directly with our clients. 


At this time, we have deferred all on site based Synroc activities. The Synroc team will continue to operate remotely to deliver on stakeholder requirements and will be in touch with clients directly should there be any relevant changes. 

Silicon Irradiation

Business operations continue as usual for the time being.

Radiation Services

Instrument calibrations are operating at regular capacity.

Training courses have now resumed. To support the health and safety of our visitors and teams we have implemented a number of additional measures. Our courses may be delivered slightly differently however this will not impact your overall learning experience.        

Radiation Consultancy work is now being undertaken in accordance with the current government guidelines. If you'd like to discuss your requirements please get in touch with the team.  

If you require more information or assistance please contact our team via or call +61 2 9717 3251. 

Health Products

covid-19 update health

As outlined above, we will work to maintain the supply of critical nuclear medicines for all Australians during this period.

We are considering the impact on local and overseas supply and are providing customer updates directly as we gain further information. If you have any questions, please contact our customer service team on 1800 251 572. 

Thank you for your support, we look forward to resuming normal operations at the appropriate time.


FacilitiesAustralian Centre for Neutron Scattering
FacilitiesAustralian Synchrotron
Nuclear medicine
FacilitiesNational Deuteration Facility